跳至主要内容
临床试验/NCT00154362
NCT00154362已完成4 期

A Multi-center, Randomized, Double-blind, Cross-over, Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Oxcarbazepine p.o. (300-1200 mg/Day) as Adjuvant Therapy for Impulsivity and Aggressive Behavior in Conduct Disorders in Adolescents

Novartis0 个研究点目标入组 50 人开始时间: 2003年4月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Novartis
入组人数
50
主要终点
Percentage reduction on Impulsivity Rating Scale (IRS)

研究概览

简要总结

Conduct disorder is a group of psychiatric symptoms that can include clinical characteristics of impulsivity and aggressive behavior. This study will investigate the efficacy a safety of oxcarbazepine in the treatment of adolescents with conduct disorder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double

入排标准

年龄范围
6 Years 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • History of conduct disorder, oppositional defiant disorder, and disruptive behavior disorder not otherwise specified
  • Score >8 on the Impulsivity Rating Scale

排除标准

  • Other serious medical or psychiatric conditions excluding conduct disorder, oppositional defiant disorder, and disruptive behavior disorder not otherwise specified
  • Treatment with antiepileptic medications
  • Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

Percentage reduction on Impulsivity Rating Scale (IRS)

次要结局

  • Percent reduction in the Modified Overt Aggression Scale (MOAS)

研究者

发起方
Novartis
申办方类型
Industry
责任方
Sponsor

相似试验

已完成
4 期
The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.Bipolar Disorder
NCT00154323Novartis55
已完成
4 期
Minocycline for SchizophreniaSchizophrenia
NCT01809158Addis Ababa University150
终止
不适用
Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)Schizophrenia
NCT00885690University of Aarhus11
已完成
不适用
Exploring the Comorbidity Between Mental Disorders and General Medical ConditionsOrganic, Including Symptomatic, Mental DisordersSubstance UseMood [Affective] DisordersNeurotic, Stress-related and Somatoform DisordersEating DisorderDisorders of Adult Personality and BehaviorDisorder of Psychological DevelopmentBehavioural DisorderSchizophreniaDyslipidemiasChronic GastritisIschemic Heart DiseasePeripheral Occlusive DiseaseThyroid DisorderGoutChronic Pulmonary DiseaseChronic Liver DiseaseInflammatory Bowel DiseasesDiverticular Disease of Large IntestineChronic Kidney DiseasesStrokeHypertensionHeart FailureAtrial FibrillationDiabetes MellitusProstate DisordersConnective Tissue DisorderPainHIV/AIDSVision DisordersHearing DisordersNeuropathyCancerMultiple SclerosisEpilepsyOsteoporosisMigraineAnemiaParkinson DiseaseAllergyMental Retardation
NCT03847753University of Aarhus5,940,299
招募中
不适用
Clinical and Social Trajectories of Children and Adolescents With Disruptive BehaviorDisruptive Behavior Disorder
NCT02812537Hospices Civils de Lyon500